We perform the group classification of a bond-pricing partial differential equation of mathematical finance to discover the combinations of arbitrary parameters that allow the partial differential equation to admit a nontrivial symmetry Lie algebra. As a result of the group classification we propose "natural" values for the arbitrary parameters in the partial differential equation, some of which validate the choices of parameters in such classical models as that of Vasicek and Cox-Ingersoll-Ross. For each set of these natural parameter values we compute the admitted Lie point symmetries, identify the corresponding symmetry Lie algebra and solve the partial differential equation.
Benth and Karlsen [F.E. Benth, K.H. Karlsen, A note on Merton's portfolio selection problem for the Schwartz mean-reversion model, Stoch. Anal. Appl. 23 (2005) 687-704] treated a problem of the optimisation of the selection of a portfolio based upon the Schwartz mean-reversion model. The resultingHamilton-Jacobi-Bellman equation in 1 + 2 dimensions is quite nonlinear. The solution obtained by Benth and Karlsen was very ingenious. We provide a solution of the problem based on the application of the Lie theory of continuous groups to the partial differential equation and its associated boundary and terminal conditions.
SUMMARYWe compute prices of zero-coupon bonds in the Vasicek and Cox-Ingersoll-Ross interest rate models as group-invariant solutions. Firstly, we determine the symmetries of the valuation partial differential equation that are compatible with the terminal condition and then seek the desired solution among the invariant solutions arising from these symmetries. We also point to other possible studies on these models using the symmetries admitted by the valuation partial differential equations.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.